|
[1]
|
中华人民共和国卫生部. WS3-B-3935-98. 中药成方制剂药品标准. 胃疡宁丸[S]. 北京: 中华人民共和国卫生部药典委员会, 1998.
|
|
[2]
|
何风雷, 郑华珠, 石洪超, 等. HPLC法测定胃疡宁丸中芍药苷的含量[J]. 中国医药导报, 2017, 14(9): 133-135.
|
|
[3]
|
黄思明, 梁志健, 操红缨, 等. 胃疡宁丸抗炎镇痛的药效研究[J]. 中药与临床, 2015(2): 64-67.
|
|
[4]
|
许艺飞, 江伟雯, 邝兆进, 等. 胃疡宁丸体内外抗幽门螺杆菌的实验研究[J]. 中药新药与临床药理, 2014(5): 572-576.
|
|
[5]
|
刘静, 黄萍, 吴清和, 等. 胃疡宁丸对胃肠运动影响的研究[J]. 中国实验方剂学杂志, 2013(10): 283-285.
|
|
[6]
|
徐晶晶, 黄萍, 吴清和, 等. 胃疡宁丸抗实验性胃溃疡的药效及机制研究[J]. 中国中药杂志, 2013, 38(5): 736-739.
|
|
[7]
|
李诗慧, 何广俊, 卢映, 等. HPLC法测定胃疡宁丸中乌药醚内酯的含量[J].中国医药指南, 2015, 13(6): 32-33.
|
|
[8]
|
邢梦雨, 田崇梅, 夏道宗. 乌药化学成分及药理作用研究进展[J]. 天然产物研究与开发, 2017, 29(12): 153-157.
|
|
[9]
|
韦震鸣, 傅强, 李志樑, 等. 去甲乌药碱对2型心肾综合征大鼠心肾的保护作用[J]. 实用医学杂志, 2018, 34(11): 1830-1833.
|
|
[10]
|
Yang, S., Chu, S., Ai, Q., et al. (2020) Anti-Inflammatory Effects of Higenamine (Hig) on LPS-Activated Mouse Microglia (BV2) through NF-κB and Nrf2/HO-1 Signaling Pathways. International Immunopharmacology, 85, Article ID: 106629. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Romeo, I., Parise, A., Galano, A., et al. (2020) The Antioxidant Capability of Higenamine: Insights from Theory. Antioxidants, 9, 358. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Yen, C.-C., Tung, C.-W., Chang, C.-W., et al. (2020) Potential Risk of Higenamine Misuse in Sports: Evaluation of Lotus Plumule Extract Products and a Human Study. Nutrients, 12, 285. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhang, Y., Zhang, J., Wu, C., et al. (2019) Higenamine Protects Neuronal Cells from Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury. Journal of Cellular Biochemistry, 120, 3757-3764. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Wang, Y., Geng, J., Jiang, M., et al. (2019) The Cardiac Electrophysiology Effects of Higenamine in Guinea Pig Heart. Biomedicine & Pharmacotherapy, 109, 2348-2356. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
曹艳, 王自正, 王峰, 等. 盐酸去甲乌药碱心肌负荷试验对心率、血压、心肌耗氧量的影响[J]. 中国医院药学杂志, 2012(17): 1353-1355.
|
|
[16]
|
宋莉, 贾琦, 周银银, 等. 基于生物大数据库分析并验证附子去甲乌药碱抗肿瘤潜在作用机制[J]. 南京中医药大学学报, 2020(5): 655-660.
|